Home / Health / Lawsuit Aims to Dismantle FTC's Health Claim Regulations

Lawsuit Aims to Dismantle FTC's Health Claim Regulations

Summary

  • Lawsuit by supplement maker Xlear challenges FTC's evidence requirements
  • Trump administration loosening enforcement of unproven health claims
  • Alternative medicine advocates see "once-in-a-lifetime opportunity" under new HHS secretary

As of August 22nd, 2025, a lawsuit filed by supplement maker Xlear threatens to upend the Federal Trade Commission's (FTC) longstanding requirement for companies to substantiate any health claims about their products. The lawsuit, which was filed in June, seeks to prohibit the FTC from demanding convincing evidence, such as clinical trials, to back up marketing claims.

This legal challenge comes amid a broader push by the Trump administration to loosen enforcement of unproven health claims by the FTC, the Department of Justice, and the Food and Drug Administration. Allies of the "medical freedom" movement, including alternative medicine practitioners and vaccine skeptics, see this as a "once-in-a-lifetime opportunity" under the new Health and Human Services (HHS) secretary, Robert F. Kennedy Jr.

The FTC has traditionally played a key role in policing the supplement industry, successfully suing companies that make unsupported health claims. However, the agency has faced staffing shortages and a more hands-off approach under the Trump administration. If Xlear's lawsuit succeeds, it would be a "complete game changer," allowing companies to make virtually any claim about their products without fear of regulatory action.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

The Xlear lawsuit challenges the FTC's longstanding requirement for companies to provide substantial evidence, such as clinical trials, to back up any health claims about their products.
The Trump administration has loosened enforcement of unproven health claims by the FTC, DOJ, and FDA, emboldening alternative medicine advocates who see an opportunity under the new HHS secretary, Robert F. Kennedy Jr.
If the Xlear lawsuit is successful, it would be a "complete game changer," allowing companies to make virtually any health claim about their products without fear of regulatory action from the FTC.

Read more news on